Abstract
National Comprehensive Cancer Network HCC guidelines recommend Y-90 to treat BCLC C patients only in select cases given the development of systemic regimens. We sought to identify ideal candidates for Y-90.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
